Literature DB >> 30420311

Chromatin condensation, fragmentation of DNA and differences in the epigenetic signature of infertile men.

Monica Muratori1, Christian De Geyter2.   

Abstract

Epidemiological studies report an increase of pathologies of male reproductive tracts and suggest a link between this trend and the increased exposure of men to endocrine disruptors (EDs). The mechanisms by which EDs impact male fertility are far to be elucidated although DNA, chromatin and epigenome of spermatozoa appear to be relevant targets for these molecules. Indeed, many studies report associations between increased levels of sperm DNA fragmentation (sDF) or aberrant chromatin condensation or epigenetic modifications and poor semen quality and/or infertile phenotype. In this scenario, therapies able to reduce sperm damage to DNA, chromatin and epigenome are sought. Currently, antioxidants and FSH administration is proposed for treating high levels of sDF, but whether or not such therapies are really effective is still debated. Further studies are necessary to understand the link between endocrine disruptor exposure and damage to sperm function and/or structure and thus to define effective therapeutic strategies.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  chromatin condensation; endocrine disruptors; epigenome; male infertility; sperm DNA fragmentation

Mesh:

Substances:

Year:  2018        PMID: 30420311     DOI: 10.1016/j.beem.2018.10.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  7 in total

1.  Removal of DNA-fragmented spermatozoa using flow cytometry and sorting does not improve the outcome of intracytoplasmic sperm injection.

Authors:  Christian De Geyter; Ursula Gobrecht-Keller; Astrid Ahler; Manuel Fischer
Journal:  J Assist Reprod Genet       Date:  2019-08-28       Impact factor: 3.412

2.  DNA methylation patterns vary in boar sperm cells with different levels of DNA fragmentation.

Authors:  Abdolrahman Khezri; Birgitte Narud; Else-Berit Stenseth; Anders Johannisson; Frøydis Deinboll Myromslien; Ann Helen Gaustad; Robert C Wilson; Robert Lyle; Jane M Morrell; Elisabeth Kommisrud; Rafi Ahmad
Journal:  BMC Genomics       Date:  2019-11-27       Impact factor: 3.969

Review 3.  Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility.

Authors:  Rossella Cannarella; Rosita A Condorelli; Laura M Mongioì; Sandro La Vignera; Aldo E Calogero
Journal:  Int J Mol Sci       Date:  2020-03-03       Impact factor: 5.923

4.  Oxidative Stress Is Associated with Telomere Interaction Impairment and Chromatin Condensation Defects in Spermatozoa of Infertile Males.

Authors:  Benoit Berby; Cynthia Bichara; Aurélie Rives-Feraille; Fanny Jumeau; Pierre Di Pizio; Véronique Sétif; Louis Sibert; Ludovic Dumont; Chistine Rondanino; Nathalie Rives
Journal:  Antioxidants (Basel)       Date:  2021-04-12

Review 5.  Sperm DNA integrity and male infertility: a narrative review and guide for the reproductive physicians.

Authors:  Ala'a Farkouh; Gianmaria Salvio; Shinnosuke Kuroda; Ramadan Saleh; Paraskevi Vogiatzi; Ashok Agarwal
Journal:  Transl Androl Urol       Date:  2022-07

Review 6.  Exploring the evidence for epigenetic regulation of environmental influences on child health across generations.

Authors:  Carrie V Breton; Remy Landon; Linda G Kahn; Michelle Bosquet Enlow; Alicia K Peterson; Theresa Bastain; Joseph Braun; Sarah S Comstock; Cristiane S Duarte; Alison Hipwell; Hong Ji; Janine M LaSalle; Rachel L Miller; Rashelle Musci; Jonathan Posner; Rebecca Schmidt; Shakira F Suglia; Irene Tung; Daniel Weisenberger; Yeyi Zhu; Rebecca Fry
Journal:  Commun Biol       Date:  2021-06-22

7.  Paradoxical risk of reduced fertility after exposure of prepubertal mice to vincristine or cyclophosphamide at low gonadotoxic doses in humans.

Authors:  Marion Delessard; Justine Saulnier; Ludovic Dumont; Aurélie Rives-Feraille; Nathalie Rives; Christine Rondanino
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.